Serotonin Pathway Polymorphisms and the Treatment of Major Depressive Disorder and Anxiety Disorders

Abstract excerpt

While antidepressants are widely used to treat major depressive disorder and anxiety disorders, only half of the patients will respond to antidepressant treatment and only a third of patients will experience a remission of symptoms. Identification of genetic biomarkers that predict antidepressant treatment response could thus greatly improve current clinical practice by providing guidance on which drug to use for...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Neurotransmitter Receptor Influence on Behavior
• Share to Receptor Mechanisms and Signaling
• Share to Treatment of Major Depression